Recent studies have demonstrated significant up-regulation of ACSL1 and ACSL3 protein levels in highly metastatic ovarian cancer cell lines, with gene expression associated with increased metastatic capacity and poor survival prognosis (60). Here, ACSL3 is linked to ovarian carcinoma.